The DOI matches its Crossref record; 106 of the 106 references it cites were found in a registry or an index.
The Utility of Biomarkers in the Diagnosis and Therapy of Inflammatory Bowel Disease
Open accessAbstract
Fecal and serologic biomarkers can be used in the diagnosis and management of inflammatory bowel disease (IBD). Fecal markers such as calprotectin and lactoferrin have been studied for their ability to identify patients with IBD, assess disease activity, and predict relapse. Antibodies against Saccharomyces cerevisiae and perinuclear antineutrophil cytoplasmic proteins have been used in diagnosis of IBD, to distinguish Crohn's disease (CD) from ulcerative colitis, and to predict the risk of complications of CD. Tests for c-reactive protein and erythrocyte sedimentation rate have been used to assess inflammatory processes and predict the course of IBD progression. Levels of drug metabolites and antibodies against therapeutic agents might be measured to determine why patients do not respond to therapy and to select alternative treatments. This review addresses the potential for biomarker assays to improve treatment strategies and challenges to their use and development.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease
Colombel, J. F., Sandborn, W. J., Reinisch, W., Mantzaris, G. J., Kornbluth, A., Rachmilewitz, D., Lichtiger, S., D'Haens, G., Diamond, R. H., Broussard, D. L., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0904492 · Cited by 3,143
Influence of Immunogenicity on the Long-Term Efficacy of Infliximab in Crohn's Disease
Baert, F., Noman, M., Vermeire, S., Van Assche, G., D' Haens, G., Carbonez, A., & Rutgeerts, P. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa020888 · Cited by 2,015
Predictability of the postoperative course of Crohn's disease
Rutgeerts, P., Geboes, K., Vantrappen, G., Beyls, J., Kerremans, R., & Hiele, M. (1990) · Gastroenterology · doi:10.1016/0016-5085(90)90613-6 · Cited by 1,820
Mucosal Healing in Inflammatory Bowel Disease: Results From a Norwegian Population-Based Cohort
Frøslie, K. F., Jahnsen, J., Moum, B. A., & Vatn, M. H. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.05.051 · Cited by 1,121
Laboratory markers in IBD: useful, magic, or unnecessary toys?
Vermeire, S., Van Assche, G., & Rutgeerts, P. (2006) · Gut · doi:10.1136/gut.2005.069476 · Cited by 952
Mucosal Healing Predicts Sustained Clinical Remission in Patients With Early-Stage Crohn's Disease
Baert, F., Moortgat, L., Van Assche, G., Caenepeel, P., Vergauwe, P., De Vos, M., Stokkers, P., Hommes, D., Rutgeerts, P., Vermeire, S., et al. (2010) · Gastroenterology · doi:10.1053/j.gastro.2009.09.056 · Cited by 830
Thia, K. T., Sandborn, W. J., Harmsen, W. S., Zinsmeister, A. R., & Loftus, E. V. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.06.070 · Cited by 792
Predicting outcome in severe ulcerative colitis.
Travis, S. P., Farrant, J. M., Ricketts, C., Nolan, D. J., Mortensen, N. M., Kettlewell, M. G., & Jewell, D. P. (1996) · Gut · doi:10.1136/gut.38.6.905 · Cited by 788
Tibble, J. A., Sigthorsson, G., Bridger, S., Fagerhol, M. K., & Bjarnason, I. (2000) · Gastroenterology · doi:10.1053/gast.2000.8523 · Cited by 759
van Rheenen, P. F., Van de Vijver, E., & Fidler, V. (2010) · BMJ · doi:10.1136/bmj.c3369 · Cited by 714
Assessment of the Neutrophil Dominating Protein Calprotectin in Feces: A Methodologic Study
RØseth, A. G., Fagerhol, M. K., Aadland, E., & Schjønsby, H. (1992) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365529209011186 · Cited by 669
Maser, E. A., Villela, R., Silverberg, M. S., & Greenberg, G. R. (2006) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2006.06.025 · Cited by 613
Langhorst, J., Elsenbruch, S., Koelzer, J., Rueffer, A., Michalsen, A., & Dobos, G. J. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01556.x · Cited by 591
Solem, C. A., Loftus, E. V., Tremaine, W. J., Harmsen, W. S., Zinsmeister, A. R., & Sandborn, W. J. (2005) · Inflammatory Bowel Diseases · doi:10.1097/01.mib.0000173271.18319.53 · Cited by 587
Schoepfer, A. M., Beglinger, C., Straumann, A., Trummler, M., Vavricka, S. R., Bruegger, L. E., & Seibold, F. (2010) · American Journal of Gastroenterology · doi:10.1038/ajg.2009.545 · Cited by 570
Costa, F., Mumolo, M. G., Ceccarelli, L., Bellini, M., Romano, M. R., Sterpi, C., Ricchiuti, A., Marchi, S., & Bottai, M. (2005) · Gut · doi:10.1136/gut.2004.043406 · Cited by 550
Seow, C. H., Newman, A., Irwin, S. P., Steinhart, A. H., Silverberg, M. S., & Greenberg, G. R. (2010) · Gut · doi:10.1136/gut.2009.183095 · Cited by 536
Mow, W. S., Vasiliauskas, E. A., Lin, Y.-C., Fleshner, P. R., Papadakis, K. A., Taylor, K. D., Landers, C. J., Abreu-Martin, M. T., Rotter, J. I., Yang, H., et al. (2004) · Gastroenterology · doi:10.1053/j.gastro.2003.11.015 · Cited by 517
Metabolomics Reveals Metabolic Biomarkers of Crohn's Disease
Jansson, J., Willing, B., Lucio, M., Fekete, A., Dicksved, J., Halfvarson, J., Tysk, C., & Schmitt-Kopplin, P. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006386 · Cited by 512
A simple method for assessing intestinal inflammation in Crohn's disease
Tibble, J., Teahon, K., Thjodleifsson, B., Roseth, A., Sigthorsson, G., Bridger, S., Foster, R., Sherwood, R., Fagerhol, M., & Bjarnason, I. (2000) · Gut · doi:10.1136/gut.47.4.506 · Cited by 492
Clinical, biological, and histologic parameters as predictors of relapse in ulcerative colitis
Bitton, A., Peppercorn, M. A., Antonioli, D. A., Niles, J. L., Shah, S., Bousvaros, A., Ransil, B., Wild, G., Cohen, A., Deb Edwardes, M. D., et al. (2001) · Gastroenterology · doi:10.1053/gast.2001.20912 · Cited by 490
Afif, W., Loftus, E. V., Faubion, W. A., Kane, S. V., Bruining, D. H., Hanson, K. A., & Sandborn, W. J. (2010) · American Journal of Gastroenterology · doi:10.1038/ajg.2010.9 · Cited by 486
Sipponen, T., Savilahti, E., Kolho, K.-L., Nuutinen, H., Turunen, U., & Färkkilä, M. (2008) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20312 · Cited by 480
Karmiris, K., Paintaud, G., Noman, M., Magdelaine–Beuzelin, C., Ferrante, M., Degenne, D., Claes, K., Coopman, T., Van Schuerbeek, N., Van Assche, G., et al. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.07.062 · Cited by 478
Targan, S. R., Landers, C. J., Yang, H., Lodes, M. J., Cong, Y., Papadakis, K. A., Vasiliauskas, E., Elson, C. O., & Hershberg, R. M. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.03.046 · Cited by 476
Jones, J., Loftus, E. V., Panaccione, R., Chen, L., Peterson, S., Mcconnell, J., Baudhuin, L., Hanson, K., Feagan, B. G., Harmsen, S. W., et al. (2008) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2008.06.010 · Cited by 414
Diagnostic Precision of Fecal Calprotectin for Inflammatory Bowel Disease and Colorectal Malignancy
von Roon, A. C., Karamountzos, L., Purkayastha, S., Reese, G. E., Darzi, A. W., Teare, J. P., Paraskeva, P., & Tekkis, P. P. (2007) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01126.x · Cited by 401
Osterman, M. T., Kundu, R., Lichtenstein, G. R., & Lewis, J. D. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.01.046 · Cited by 394
Self-citationIntestinal cancer risk and mortality in patients with Crohn's disease
Munkholm, P., Langholz, E., Davidsen, M., & Binder, V. (1993) · Gastroenterology · doi:10.1016/0016-5085(93)91068-s · Cited by 379
Diagnostic accuracy of serological assays in pediatric inflammatory bowel disease
Ruemmele, F. M., Targan, S. R., Levy, G., Dubinsky, M., Braun, J., & Seidman, E. G. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70252-5 · Cited by 379
Røseth, A. G., Aadland, E., Jahnsen, J., & Raknerud, N. (1997) · Digestion · doi:10.1159/000201441 · Cited by 365
Fecal lactoferrin is a sensitive and specific marker in identifying intestinal inflammation
Kane, S. (2003) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(03)00232-6 · Cited by 364
The value of serologic markers in indeterminate colitis: A prospective follow-up study
Joossens, S., Reinisch, W., Vermeire, S., Sendid, B., Poulain, D., Peeters, M., Geboes, K., Bossuyt, X., Vandewalle, P., Oberhuber, G., et al. (2002) · Gastroenterology · doi:10.1053/gast.2002.32980 · Cited by 333
Schoepfer, A. M., Beglinger, C., Straumann, A., Trummler, M., Renzulli, P., & Seibold, F. (2009) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20986 · Cited by 326
SIPPONEN, T., KÄRKKÄINEN, P., SAVILAHTI, E., KOLHO, K. ‐., NUUTINEN, H., TURUNEN, U., & FÄRKKILÄ, M. (2008) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2008.03835.x · Cited by 324
Fecal calprotectin and lactoferrin for the prediction of inflammatory bowel disease relapse
Gisbert, J. P., Bermejo, F., Pérez-Calle, J.-L., Taxonera, C., Vera, I., McNicholl, A. G., Algaba, A., López, P., López-Palacios, N., Calvo, M., et al. (2009) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20933 · Cited by 315
Serum levels of C‐reactive protein in Crohn's disease and ulcerative colitis
FAGAN, E. A., DYCK, R. F., MATON, P. N., HODGSON, H. J. F., CHADWICK, V. S., PETRIE, A., & PEPYS, M. B. (1982) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1982.tb02244.x · Cited by 311
Ferrante, M., Henckaerts, L., Joossens, M., Pierik, M., Joossens, S., Dotan, N., Norman, G. L., Altstock, R. T., Van Steen, K., Rutgeerts, P., et al. (2007) · Gut · doi:10.1136/gut.2006.108043 · Cited by 292
Romberg-Camps, M. J. L., Dagnelie, P. C., Kester, A. D. M., Hesselink-van de Kruijs, M. A. M., Cilissen, M., Engels, L. G. J. B., Van Deursen, C., Hameeteman, W. H. A., Wolters, F. L., Russel, M. G. V. M., et al. (2009) · The American Journal of Gastroenterology · doi:10.1038/ajg.2008.38 · Cited by 286
Dubinsky, M. C., Lin, Y.-C., Dutridge, D., Picornell, Y., Landers, C. J., Farrior, S., Wrobel, I., Quiros, A., Vasiliauskas, E. A., Grill, B., et al. (2006) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00456.x · Cited by 286
Saverymuttu, S. H., Camilleri, M., Rees, H., Lavender, J. P., Hodgson, H. J. F., & Chadwick, V. S. (1986) · Gastroenterology · doi:10.1016/0016-5085(86)90376-8 · Cited by 274
Reese, G. E., Constantinides, V. A., Simillis, C., Darzi, A. W., Orchard, T. R., Fazio, V. W., & Tekkis, P. P. (2006) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00840.x · Cited by 267
Røseth, A. G., Aadland, E., & Grzyb, K. (2004) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365520410007971 · Cited by 267
Turner, D., Mack, D., Leleiko, N., Walters, T. D., Uusoue, K., Leach, S. T., Day, A. S., Crandall, W., Silverberg, M. S., Markowitz, J., et al. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.02.047 · Cited by 258
Predicting relapse in Crohn’s disease: a biopsychosocial model
Bitton, A., Dobkin, P. L., Edwardes, M. D., Sewitch, M. J., Meddings, J. B., Rawal, S., Cohen, A., Vermeire, S., Dufresne, L., Franchimont, D., et al. (2008) · Gut · doi:10.1136/gut.2007.134817 · Cited by 254
Increased Immune Reactivity Predicts Aggressive Complicating Crohn's Disease in Children
Dubinsky, M. C., Kugathasan, S., Mei, L., Picornell, Y., Nebel, J., Wrobel, I., Quiros, A., Silber, G., Wahbeh, G., Katzir, L., et al. (2008) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2008.04.032 · Cited by 245
Sipponen, T., Savilahti, E., Kärkkäinen, P., Kolho, K.-L., Nuutinen, H., Turunen, U., & Färkkilä, M. (2008) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20490 · Cited by 236
Antibodies Against Laminaribioside and Chitobioside Are Novel Serologic Markers in Crohn’s Disease
Dotan, I., Fishman, S., Dgani, Y., Schwartz, M., Karban, A., Lerner, A., Weishauss, O., Spector, L., Shtevi, A., Altstock, R. T., et al. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.04.030 · Cited by 234
Picco, M. F. (2009) · Yearbook of Gastroenterology · doi:10.1016/s0739-5930(09)79277-3 · Cited by 225
Taylor, K. D., Yang, H., Landers, C. J., Rotter, J. I., Targan, S. R., Plevy, S. E., & Barry, M. J. (2001) · Gastroenterology · doi:10.1053/gast.2001.23966 · Cited by 222
Calprotectin and lactoferrin in the assessment of intestinal inflammation and organic disease
D’Incà, R., Dal Pont, E., Di Leo, V., Ferronato, A., Fries, W., Vettorato, M. G., Martines, D., & Sturniolo, G. C. (2007) · International Journal of Colorectal Disease · doi:10.1007/s00384-006-0159-9 · Cited by 215
Kaiser, T., Langhorst, J., Wittkowski, H., Becker, K., Friedrich, A. W., Rueffer, A., Dobos, G. J., Roth, J., & Foell, D. (2007) · Gut · doi:10.1136/gut.2006.113431 · Cited by 212
Can Calprotectin Predict Relapse Risk in Inflammatory Bowel Disease?
D'Incà, R., Dal Pont, E., Di Leo, V., Benazzato, L., Martinato, M., Lamboglia, F., Oliva, L., & Carlo Sturniolo, G. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2008.01870.x · Cited by 211
Standaert–Vitse, A., Jouault, T., Vandewalle, P., Mille, C., Seddik, M., Sendid, B., Mallet, J., Colombel, J., & Poulain, D. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.02.009 · Cited by 210
Predictors of early response to infliximab in patients with ulcerative colitis
Ferrante, M., Vermeire, S., Katsanos, K. H., Noman, M., Van Assche, G., Schnitzler, F., Arijs, I., De Hertogh, G., Hoffman, I., Geboes, K., et al. (2007) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20054 · Cited by 192
McKenzie, H., Main, J., Pennington, C. R., & Parratt, D. (1990) · Gut · doi:10.1136/gut.31.5.536 · Cited by 180
Sugi, K., Saitoh, O., Hirata, I., & Katsu, K. (1996) · PubMed · Cited by 172
Fecal Calprotectin Predicts the Clinical Course of Acute Severe Ulcerative Colitis
Ho, G. T., Lee, H. M., Brydon, G., Ting, T., Hare, N., Drummond, H., Shand, A. G., Bartolo, D. C., Wilson, R. G., Dunlop, M. G., et al. (2009) · The American Journal of Gastroenterology · doi:10.1038/ajg.2008.119 · Cited by 171
Boirivant, M., Leoni, M., Tariciotti, D., Fais, S., Squarcia, O., & Pallone, F. (1988) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-198808000-00011 · Cited by 170
Wagner, M. S., Peterson, C. G. B., Ridefelt, P., Sangfelt, P., & Carlson, M. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.5584 · Cited by 164
Langhorst, J., Elsenbruch, S., Mueller, T., Rueffer, A., Spahn, G., Michalsen, A., & Dobos, G. J. (2005) · Inflammatory Bowel Diseases · doi:10.1097/01.mib.0000187980.08686.18 · Cited by 162
A laboratory index for predicting relapse in asymptomatic patients with Crohn's disease
Brignola, C., Campieri, M., Bazzocchi, G., Farruggia, P., Tragnone, A., & Lanfranchi, G. A. (1986) · Gastroenterology · doi:10.1016/0016-5085(86)90206-4 · Cited by 159
Sipponen, T. M., af Björkesten, C.-G., Färkkilä, M. A., Nuutinen, H. U., Savilahti, E., & Kolho, K. (2009) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365520903483650 · Cited by 155
Faecal calprotectin or lactoferrin can identify postoperative recurrence in Crohn's disease
Lamb, C. A., Mohiuddin, M. K., Gicquel, J., Neely, D., Bergin, F. G., Hanson, J. M., & Mansfield, J. C. (2009) · British journal of surgery · doi:10.1002/bjs.6593 · Cited by 142
Fecal calprotectin is useful in predicting disease relapse in pediatric inflammatory bowel disease
Walkiewicz, D., Werlin, S. L., Fish, D. L., Scanlon, M. C., Hanaway, P. J., & Kugathasan, S. (2008) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20376 · Cited by 142
Esters, N., Vermeire, S., Joossens, S. B. A., Noman, M., Louis, E., Bélaïche, J., Vos, M. D., Gossum, A. M. V., Pescatore, P., Fiasse, R., et al. (2002) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2002.05689.x · Cited by 142
Faecal markers in the assessment of activity in inflammatory bowel disease
Poullis, A. P., Foster, R., Northfield, T. C., & Mendall, M. A. (2002) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2002.01196.x · Cited by 139
Fagerberg, U. L., Lööf, L., Lindholm, J., Hansson, L., & Finkel, Y. (2007) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0b013e31810e75a9 · Cited by 138
Dubinsky, M. C., Mei, L., Friedman, M., Dhere, T., Haritunians, T., Hakonarson, H. H., Kim, C., Glessner, J., Targan, S. R., McGovern, D. P. B., et al. (2009) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21174 · Cited by 136
Enzymes in feces: Useful markers of chronic inflammatory bowel disease
Angriman, I., Scarpa, M., Renata D'Incà, Basso, D., Ruffolo, C., Polese, L., Sturniolo, G. C., D'Amico, D. F., & Plebani, M. (2007) · Clinica Chimica Acta · doi:10.1016/j.cca.2007.02.025 · Cited by 135
Red Cell Distribution Width for Assessment of Activity of Inflammatory Bowel Disease
Çakal, B., Aköz, A. G., Üstündağ, Y., Yalinkilic, M., Ülker, A., & Ankaralı, H. Ç. (2008) · Digestive Diseases and Sciences · doi:10.1007/s10620-008-0436-2 · Cited by 134
Gisbert, J. P., McNicholl, A. G., & Gomollón, F. (2009) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20920 · Cited by 132
Turner, D., Leach, S. T., Mack, D. R., Uusoue, K., McLernon, R., Hyams, J. S., LeLeiko, N. S., Walters, T. D., Crandall, W., Markowitz, J. F., et al. (2010) · Gut · doi:10.1136/gut.2010.211755 · Cited by 132
Amre, D. K., Lu, S., Costea, F., & Seidman, E. G. (2006) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00468.x · Cited by 126
Poullis, A. P., Zar, S., Sundaram, K. K., Moodie, S. J., Risley, P., Theodossi, A., & Mendall, M. A. (2002) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-200204000-00013 · Cited by 122
Hanai, H., Takeuchi, K., Iida, T., Kashiwagi, N., Saniabadi, A. R., Matsushita, I., Sato, Y., Kasuga, N., & Nakamura, T. (2004) · Digestive Diseases and Sciences · doi:10.1023/b:ddas.0000042243.47279.87 · Cited by 122
Nielsen, O. H., Gionchetti, P., Ainsworth, M. A., Vainer, B., Campieri, M., Borregaard, N., & Kjeldsen, L. (1999) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.1999.01439.x · Cited by 120
Orlando, A., Modesto, I., Castiglione, F., Scala, L., Scimeca, D., Rispo, A., Teresi, S., Mocciaro, F., Criscuoli, V. V., Marrone, C., et al. (2006) · PubMed · Cited by 120
Fecal Eosinophil Granule-Derived Proteins Reflect Disease Activity in Inflammatory Bowel Disease
Saitoh, O., Kojima, K., Sugi, K., Matsuse, R., Uchida, K., Tabata, K., Nakagawa, K., Kayazawa, M., Hirata, I., & Katsu, K. (1999) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.1999.01640.x · Cited by 119
C-Reactive protein as an aid in the differentiation of functional and inflammatory bowel disorders
Shine, B. S. F., Berghouse, L., Lennard‐Jones, J. E., & Landon, J. (1985) · Clinica Chimica Acta · doi:10.1016/0009-8981(85)90219-0 · Cited by 116
Fecal leukocyte proteins in inflammatory bowel disease and irritable bowel syndrome.
Silberer, H., Küppers, B., Mickisch, O., Baniewicz, W., Drescher, M., Traber, L., Kempf, A., & Schmidt‐Gayk, H. (2005) · PubMed · Cited by 114
Indications for investigation of chronic gastrointestinal symptoms.
Beattie, R. M., Walker-Smith, J. A., & MURCH, S. H. (1995) · Archives of Disease in Childhood · doi:10.1136/adc.73.4.354 · Cited by 110
A simple biological score for predicting low risk of short-term relapse in Crohnʼs disease
Consigny, Y., Modigliani, R., Colombel, J., Dupas, J., Lémann, M., & Mary, J. (2006) · Inflammatory Bowel Diseases · doi:10.1097/01.ibd.0000225334.60990.5b · Cited by 105
Fecal S100A12: A novel noninvasive marker in children with Crohnʼs disease
de Jong, N., Leach, S. T., & Day, A. S. (2006) · Inflammatory Bowel Diseases · doi:10.1097/01.ibd.0000227626.72271.91 · Cited by 105
Fecal Lactoferrin and Calprotectin After Ileocolonic Resection for Crohn's Disease
Scarpa, M., Renata D'Incà, Basso, D., Ruffolo, C., Polese, L., Bertin, E., Luise, A., Frego, M., Plebani, M., Sturniolo, G. C., et al. (2007) · Diseases of the Colon & Rectum · doi:10.1007/s10350-007-0225-6 · Cited by 103
Fecal M2-pyruvate kinase (M2-PK): A novel marker of intestinal inflammation
Chung‐Faye, G., Hayee, B., Maestranzi, S., Donaldson, N., Forgács, I., & Sherwood, R. A. (2007) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20214 · Cited by 101
Lundberg, J. O., Hellström, P. M., Fagerhol, M. K., Weitzberg, E., & Røseth, A. G. (2005) · Nature Clinical Practice Gastroenterology & Hepatology · doi:10.1038/ncpgasthep0094 · Cited by 98
Haines, M. L., Ajlouni, Y., Irving, P. M., Sparrow, M., Rose, R., Gearry, R. B., & Gibson, P. R. (2010) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21458 · Cited by 98
Oussalah, A., Chevaux, J., Fay, R., Sandborn, W. J., Bigard, M., & Peyrin‐Biroulet, L. (2010) · The American Journal of Gastroenterology · doi:10.1038/ajg.2010.158 · Cited by 96
Farup, P. G., Hovde, Ø., Halvorsen, F.-A., Raknerud, N., & Brodin, U. (1995) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365529509093256 · Cited by 93
Faecal calprotectin in children with clinically quiescent inflammatory bowel disease
Sipponen, T. M., & Kolho, K. (2010) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365521003782389 · Cited by 93
Fecal Calprotectin and Lactoferrin as Noninvasive Markers of Pediatric Inflammatory Bowel Disease
Joishy, M., Davies, I. H., Ahmed, M., Wassell, J., Davies, K., Sayers, A. E., & Jenkins, H. R. (2009) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0b013e31816533d3 · Cited by 91
Fecal levels of leukocyte markers reflect disease activity in patients with ulcerative colitis
Peterson, C. G. B., Sangfelt, P., Wagner, M., Hansson, T., Lettesjö, H., & Carlson, M. (2007) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/00365510701452838 · Cited by 85
Waljee, A. K., Joyce, J. C., Wang, S., Saxena, A., Hart, M., Zhu, J., & Higgins, P. (2009) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2009.09.031 · Cited by 82
CRP Correlates with Clinical Score in Ulcerative Colitis but Not in Crohn’s Disease
Rodgers, A. D., & Cummins, A. G. (2007) · Digestive Diseases and Sciences · doi:10.1007/s10620-006-9691-2 · Cited by 81
Masoodi, I., Kochhar, R. K., Dutta, U., Vaishnavi, C. V., Prasad, K. K., Vaiphei, K., Kaur, S., & Singh, K. (2009) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2009.06048.x · Cited by 68
Anti-outer membrane of porin C and anti-I2 antibodies in indeterminate colitis
Joossens, S. B. A., Colombel, J. F., Landers, C. J., Poulain, D., Geboes, K. J., Bossuyt, X., Targan, S. R., Rutgeerts, P., & Reinisch, W. (2006) · Gut · doi:10.1136/gut.2005.089623 · Cited by 68
Antibodies to I2 predict clinical response to fecal diversion in Crohnʼs disease
Spivak, J., Landers, C. J., Vasiliauskas, E. A., Abreu, M. T., Dubinsky, M. C., Papadakis, K. A., Ippoliti, A., Targan, S. R., & Fleshner, P. R. (2006) · Inflammatory Bowel Diseases · doi:10.1097/01.mib.0000235833.47423.d7 · Cited by 61
Shortcomings of the Inflammatory Bowel Disease Serology 7 Panel
Benor, S., Russell, G. H., Silver, M., Israel, E. J., Yuan, Q., & Winter, H. S. (2010) · PEDIATRICS · doi:10.1542/peds.2009-1936 · Cited by 60
Sabery, N., & Bass, D. (2006) · PEDIATRICS · doi:10.1542/peds.2006-1361 · Cited by 47
Manolakis, A. C., Kapsoritakis, A. N., Georgoulias, P., Tzavara, C. K., Valotassiou, V. J., Kapsoritaki, A. I., & Potamianos, S. P. (2010) · BMC Gastroenterology · doi:10.1186/1471-230x-10-118 · Cited by 46
Simondi, D., Mengozzi, G., Betteto, S., Bonardi, R., Ghignone, R. P., Fagoonee, S., Pellicano, R., Sguazzini, C., Pagni, R., Rizzetto, M., et al. (2008) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20368 · Cited by 38
C-Reactive Protein: Anti-Placebo or Predictor of Response
Lewis, J. D. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.07.041 · Cited by 32
Self-citationKhoury, P. V.-E., Colombel, J., Joossens, S. B. A., Standaert‐Vitse, A., Collot, M., Halfvarson, J., Ayadi, A., Landers, C. J., Vermeire, S., Rutgeerts, P. J., et al. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01648.x · Cited by 27
Long-Term Outcome of Crohn's Disease Following Corticosteroid-Induced Remission
Papi, C., Festa, V., Leandro, G., Moretti, A., Tanga, M., Koch, M., & Capurso, L. (2007) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01055.x · Cited by 25
Casellas, F., Antolı́n, M., Varela, E., Garcia-Lafuente, A. M., Guarner, F., Borruel, N., Miró, J. R. A., & Malagelada, J. (2004) · Clinical Gastroenterology and Hepatology · doi:10.1016/s1542-3565(04)00291-5 · Cited by 18
Cited by
Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis
Feagan, B. G., Rutgeerts, P., Sands, B. E., Hanauer, S., Colombel, J.-F., Sandborn, W. J., Van Assche, G., Axler, J., Kim, H.-J., Danese, S., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1215734 · Cited by 2,888
Baumgart, D. C., & Sandborn, W. J. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60026-9 · Cited by 2,154
Peyrin-Biroulet, L., Sandborn, W., Sands, B. E., Reinisch, W., Bemelman, W., Bryant, R. V., D'Haens, G., Dotan, I., Dubinsky, M., Feagan, B., et al. (2015) · American Journal of Gastroenterology · doi:10.1038/ajg.2015.233 · Cited by 1,844
Dynamics of the human gut microbiome in inflammatory bowel disease
Halfvarson, J., Brislawn, C. J., Lamendella, R., Vázquez-Baeza, Y., Walters, W. A., Bramer, L. M., D'Amato, M., Bonfiglio, F., McDonald, D., Gonzalez, A., et al. (2017) · Nature Microbiology · doi:10.1038/nmicrobiol.2017.4 · Cited by 1,204
Lewis, J. D., Chen, E. Z., Baldassano, R. N., Otley, A. R., Griffiths, A. M., Lee, D., Bittinger, K., Bailey, A., Friedman, E. S., Hoffmann, C., et al. (2015) · Cell Host & Microbe · doi:10.1016/j.chom.2015.09.008 · Cited by 823
Self-citation
Metadata
- Authors
- Lewis, J. D.
- Venue
- Gastroenterology
- Publisher
- Elsevier BV
- Published
- 2011-05
- Volume
- 140
- Issue
- 6
- Pages
- 1817-1826.e2
- ISSN
- 0016-5085 (ISSN-L)
- OpenAlex
- W2015747379
- Cited by
- 458
- References
- 106
- FWCI
- 23.20
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.